Showing results (1-10 of 103) with videos related to
Sort By:
Pageof 11
Journal of Cardiovascular Pharmacology|October 1, 1995
Selective Ik blocker almokalant exhibits class III--specific effects on the repolarization and refractoriness of the human heart: a study of healthy volunteers using right ventricular monophasic action potential recordingsB Darpö, H Vallin, O Almgren, et al.Cardiovascular Drugs and Therapy|July 1, 1997
Effects of almokalant, a class III antiarrhythmic agent, on supraventricular, reentrant tachycardias. Almokalant Paroxysmal Supraventricular Tachycardia Study GroupB Darpö, N EdvardssonJournal of Cardiovascular Pharmacology|August 1, 1995
Effect of almokalant, a selective potassium channel blocker, on the termination and inducibility of paroxysmal supraventricular tachycardias: a study in patients with Wolff-Parkinson-White syndrome and atrioventricular nodal reentrant tachycardia. Almokalant PSVT Study GroupB Darpö, N EdvardssonInternational Journal of Cardiology|March 1, 1996
Torsades de pointes induced by transesophageal atrial stimulation after administration of almokalantB Darpö, M Allared, N EdvardssonPacing and Clinical Electrophysiology : PACE|May 30, 1998
Electrocardiographic and clinical predictors of torsades de pointes induced by almokalant infusion in patients with chronic atrial fibrillation or flutter: a prospective studyB Houltz, B Darpö, N Edvardsson, et al.Cardiovascular Drugs and Therapy|October 12, 1999
Effects of the Ikr-blocker almokalant and predictors of conversion of chronic atrial tachyarrhythmias to sinus rhythm. A prospective studyB Houltz, B Darpö, K Swedberg, et al.Cardiovascular Drugs and Therapy|November 1, 1996
Assessment of frequency dependency of the class III effects of almokalant: a study using programmed stimulation and recording of monophasic action potentials and ventricular paced QT intervalsB Darpö, O Almgren, R Bergstrand, et al.British Heart Journal|September 1, 1995
Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillationM Edner, K Caidahl, L Bergfeldt, et al.The American Journal of Cardiology|December 1, 1994
Atrioventricular block progression in patients with bifascicular block assessed by repeated electrocardiography and a bradycardia-detecting pacemakerL Bergfeldt, N Edvardsson, M Rosenqvist, et al.Journal of Cardiovascular Pharmacology|May 1, 1995
Tolerance and effects of almokalant, a new selective Ik blocking agent, on ventricular repolarization and on sino-atrial and atrioventricular nodal function in the heart: a study in healthy, male volunteers utilizing transesophageal atrial stimulationB Darpö, O Almgren, R Bergstrand, et al.Pageof 11